Oral delivery product
Latest Pfizer Inc. Patents:
- Pyrrolo[2,3-d]pyrimidinyl, Pyrrolo[2,3-b]pyrazinyl and Pyrrolo[2,3-d]pyridinyl Acryla-mides
- Solid Forms of 2-[(4-{6-[(4-Cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2S)-oxetan-2-ylmethyl]-1H-benzimidazole-6-carboxylic acid, 1,3-Dihydroxy-2-(hydroxymethyl)propan-2-amine Salt
- MELANOCORTIN 4 RECEPTOR ANTAGONISTS AND USES THEREOF
- METHODS AND DOSING REGIMENS COMPRISING A CDK2 INHIBITOR FOR THE TREATMENT OF CANCER
- Pyrido[4,3-d]pyrimidine compounds
Description
Claims
The ornamental design for an oral delivery product, as shown and described.
Referenced Cited
Patent History
Patent number: D748240
Type: Grant
Filed: Oct 21, 2014
Date of Patent: Jan 26, 2016
Assignee: Pfizer Inc. (New York, NY)
Inventor: Michael A. Goode (Powhatan, VA)
Primary Examiner: Susan Bennett Hattan
Assistant Examiner: Charles Hanson
Application Number: 29/506,871
Type: Grant
Filed: Oct 21, 2014
Date of Patent: Jan 26, 2016
Assignee: Pfizer Inc. (New York, NY)
Inventor: Michael A. Goode (Powhatan, VA)
Primary Examiner: Susan Bennett Hattan
Assistant Examiner: Charles Hanson
Application Number: 29/506,871
Classifications
Current U.S. Class:
Tablet Or Caplet (1) (D24/101)